Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study
by Dimopoulos, Meletios A. (Author)
, Siegel, David S (Author)
, Lonial, Sagar (Author)
, Qi, Junyuan (Author)
, Hajek, Roman (Author)
, Facon, Thierry (Author)
, Rosinol, Laura (Author)
, Williams, Catherine (Author)
, Blacklock, Hilary (Author)
, Goldschmidt, Hartmut (Author)
, Hungria, Vania (Author)
, Spencer, Andrew (Author)
, Palumbo, Antonio (Author)
, Graef, Thorsten (Author)
, Eid, Joseph E (Author)
, Houp, Jennifer (Author)
, Sun, Linda (Author)
, Vuocolo, Scott (Author)
, Anderson, Kenneth C (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource